A high-risk pair – a drug and DNA variant increase he

St. Jude scientists identified a genetic difference in childhood cancer survivors treated with chemotherapy that predisposes them to heart problems as adults.

Related Keywords

Canada , Tennessee , United States , Texas , Weiyu Qiu , Yutaka Yasui , Zhaoming Wang , Leslie Robison , Heatherl Mulder , Jun Yang , Daniel Mulrooney , Paul Burridge , John Jefferies , Robert Michael , Ericj Chow , Chunliang Li , Ying Shao , Melissa Hudson , Asmita Bhatia , John Easton , Kevin Oeffinger , Gregory Armstrong , Jinghui Zhang , Qi Liu , Nakyla Shelton , Emily Plyler , Matthewj Ehrhardt , Lindsay Morton , Xuexia Wang , Carmen Wilson , University Of Alberta , National Cancer Institute , University Of North Texas , Jude Department Of Epidemiology , University Of Alabama At Birmingham , University Of Tennessee Heath Science Center , Northwestern University , Duke University , Fred Hutchinson Cancer Research Center , Jude Department , North Texas , Tennessee Heath Science Center , Epidemiology And Cancer Control , T Jude Cloud , Heart , Na , Doxorubicin ,